Please Wait
Applying Filters...
menu
    • menu

    List of Certificates of Suitability (CEPs) for Prestwick3_000177 Active Pharmaceutical Ingredient (API) issued by the EDQM. Original Data: EDQM Database

    Client Email Product
    US, Europe turn to advanced manufacturing, stockpiling to strengthen drug supply chains

    Data Compilation
    #PharmaFlow

    Pipeline Prospector Sept 2024: BMS wins landmark FDA approval for schizophrenia med; Sanofi’s Dupixent okayed for COPD

    Stock Recap
    #PipelineProspector

    Menu

    Prestwick3_000177

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    PRICE INFORMATION

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 11Xls download

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Data in the table can be downloaded after upgrading. In the meantime, you can access the data through the menu.

    Last Updated on PharmaCompass Virtual Booth Country Certificate Holder Certificate No. Substance Issue Date Status Type End Date Substance No.
    26/09/2024 Indosol Drugs Limited IN 400 001 Mumbai
    India
    		 Indosol Drugs Limited Mumbai IN R1-CEP 1998-049 - Rev 00 Sulfamethoxazole 2004-02-01 Withdrawn by EDQM Failure to CEP procedure Chemical 2008-05-26 108
    26/09/2024 Shouguang Fukang Pharmaceutical Co., Ltd
    China
    		 SHOUGUANG FUKANG PHARMACEUTICAL CO., LTD. Shouguang City CN R1-CEP 2007-332 - Rev 01 Sulfamethoxazole 2017-07-11 Valid Chemical 108